1. Drug discovery in pharmaceutical industry: productivity challenges and trends;Khanna;Drug Discov. Today,2011
2. A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study BMC;Dunne;Pharmacol. Toxicol.,2013
3. Statistical issues in bioavailability/bioequivalence studies;Chow;Bioequiv. Availab.,2011
4. Biosimilars: company strategies to capture value from the biologics market;Calo-Fernandez;Pharmaceuticals,2012
5. The New Copycats (2013) Engineering biosimilars, or near copies, of leading biologic drugs, pushes the limits of bioprocessing know-how;Thayer;CEN,2013